Delivery Order SPE2DB20D1004-SPE2DB25FNDAJ

Award Date 11/27/24
Potential Completion Date 11/29/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,143.87 Firm Fixed Price Delivery Order contract covers the provision of the pharmaceutical product "ZEPBOUND 10 MG/0.5 ML PEN 0.5ML" with a performance period through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,211.30 firm fixed-price delivery order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,550.83 Firm Fixed Price Delivery Order contract is for the supply of 4566615955 ! ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,371.00 firm fixed price delivery order contract is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) Troop Support Medical. The $4,371.78 firm fixed price delivery order is for the supply of "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML", a pharmaceutical product, with a completion date of November 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,982.55, is for the delivery of the pharmaceutical product "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML." The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 IDC with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,525.20, is a Delivery Order for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of December 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,726.40 firm fixed-price delivery order covers the supply of the drug product ZEPBOUND 10 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,828.53, is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of November 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,026.78, is for the delivery of a medical product, the ZEPBOUND 15 MG/0.5 ML PEN 0.5ML. This award is part of Amerisourcebergen's broader $999,999,999 IDC with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNDAJ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,019.58 fixed-price delivery order is for the supply of a specific pharmaceutical product, the ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, with a completion date of November 29, 2024.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 2/27/25, 11:31 AM